Senti Biosciences Inc (NASDAQ: SNTI) on Friday, plunged -8.19% from the previous trading day, before settling in for the closing price of $2.32. Within the past 52 weeks, SNTI’s price has moved between $1.52 and $16.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 69.24%. With a float of $7.97 million, this company’s outstanding shares have now reached $26.00 million.
Let’s look at the performance matrix of the company that is accounted for 34 employees. In terms of profitability, gross margin is 24.95%, operating margin of -1043.97%, and the pretax margin is -935.64%.
Senti Biosciences Inc (SNTI) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Senti Biosciences Inc is 69.44%, while institutional ownership is 12.76%. The most recent insider transaction that took place on Feb 04 ’25, was worth 15,963. In this transaction CEO of this company sold 3,922 shares at a rate of $4.07, taking the stock ownership to the 82,627 shares. Before that another transaction happened on Feb 06 ’25, when Company’s CEO sold 545 for $4.36, making the entire transaction worth $2,376. This insider now owns 82,082 shares in total.
Senti Biosciences Inc (SNTI) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 69.24% per share during the next fiscal year.
Senti Biosciences Inc (NASDAQ: SNTI) Trading Performance Indicators
Senti Biosciences Inc (SNTI) is currently performing well based on its current performance indicators. A quick ratio of 4.22 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.84, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Senti Biosciences Inc (SNTI)
Senti Biosciences Inc (NASDAQ: SNTI) saw its 5-day average volume 0.33 million, a positive change from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 58.59%.
During the past 100 days, Senti Biosciences Inc’s (SNTI) raw stochastic average was set at 7.19%, which indicates a significant decrease from 43.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was lower than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.85, while its 200-day Moving Average is $3.34. Nevertheless, the first resistance level for the watch stands at $2.24 in the near term. At $2.34, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.40. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $2.02. The third support level lies at $1.92 if the price breaches the second support level.
Senti Biosciences Inc (NASDAQ: SNTI) Key Stats
Market capitalization of the company is 55.55 million based on 26,081K outstanding shares. Right now, sales total 0 K and income totals -52,790 K. The company made 0 K in profit during its latest quarter, and -14,110 K in sales during its previous quarter.
